Healthcare
Technology
Data Service

NantHealth

$0.5857
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0021 (0.36%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell NantHealth and other stocks, options, ETFs, and crypto commission-free!

About

NantHealth, Inc. operates as an evidence-based, personalized healthcare company, which provides treatment for critical diseases such as cancer. It is based on personalized healthcare approach that integrates novel diagnostics with large scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. Read More The company was founded by Patrick Soon-Shiong in July 2010 and is headquartered in Culver City, CA.

Employees
Headquarters
Culver City, California
Founded
2010
Market Cap
64.38M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
191.47K
High Today
$0.6163
Low Today
$0.57
Open Price
$0.583
Volume
49.07K
52 Week High
$3.64
52 Week Low
$0.4839

Collections

Healthcare
Technology
Data Service
Cancer Prevention
Medical
Health
Software Service
2016 IPO

News

Seeking AlphaMay 11

NantHealth, Inc. CEO Patrick Soon-Shiong on Q1 2019 Results - Earnings Call Transcript

NantHealth, Inc. (NASDAQ:NH) Q1 2019 Earnings Conference Call May 9, 2018 4:30 PM ET Company Participants Robert Jaffe - Investor Relations Ronald Louks - Chief Operating Officer Bob Petrou - Interim Chief Financial Officer Patrick Soon-Shiong - Chief Executive Officer Sandeep Reddy - Chief Medical Officer Conference Call Participants Brandon Couillard - Jefferies LLC Sean Dodge - Jefferies & Co. Operator Good day, ladies and gentlemen, and welcome to the NantHealth 2019 First Quarter Financial R...

93
Yahoo FinanceMay 9

NantHealth Reports 2019 First-Quarter Financial Results

CULVER CITY, Calif.--(BUSINESS WIRE)-- Total revenue in Q1 was $23.7 million, up 7% from Q1 2018 SaaS revenue of $17.8 million in Q1, up 10% from Q1 2018 and 3% sequentially Signed Substantial Three-year Eviti Contract with Multi-state Healthcare Payer Sequencing and Molecular Analysis, 820 total tests ordered in Q1, including 428 GPS Cancer® and 392 Liquid GPSSM Tests NantHealth, Inc. (NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its firs...

60
Yahoo FinanceMay 2

NantHealth to Report 2019 First-Quarter Financial Results and Host Conference Call on Thursday, May 9

CULVER CITY, Calif.--(BUSINESS WIRE)-- NantHealth, Inc. (NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2019 first quarter on Thursday, May 9, 2019, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The conference call will be available to interested parties by dialing 844-309-3709 from the U.S. or Canada, or 281-962-4...

169

Earnings

-$0.14
-$0.12
-$0.09
-$0.07
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.10 per share
Actual
-$0.10 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.